Catalyst Wire Dossier Catalyst Wire Dossier

SUVN-I6107

SUVN-I6107 · Suven Life Sciences Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SUVN-I6107, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants [Phase 1]

See pricing